News | May 08, 2014

Elekta Launches Global Center of Excellence Program to Advance Cancer Management Efforts

Kettering Medical Center is first designated Center of Excellence

May 8, 2014 — Elekta has established a Center of Excellence program that seeks the collaboration of its clinical customers in the development of high-quality research, education and outreach to advance the treatment of cancer and brain disorders. Long-time Elekta solutions user, Kettering Medical Center (Kettering, Ohio) has been named the program's first Center of Excellence. The program seeks to provide patients suffering from cancer and brain disorders with extraordinary treatment based on a foundation of collaboration and learning with prestigious institutions and a shared commitment to clinical excellence.

"With its vast array of Elekta cancer management solutions — and more than two decades of history and collaboration with the company — Kettering Medical Center exemplifies the vision of the Center of Excellence program through its activities in its community and region and through its reputation as a world-class provider of clinical services," says Jay Hoey, executive vice president, Elekta North America. "We are proud to designate Kettering as the first such center."

According to Douglas B. Einstein, M.D., Ph.D., medical director and chairman of radiation oncology, Kettering Health Network, Elekta, Kettering and its patients will benefit from the center's participation in the Center of Excellence program. "Together, we have created a center that provides academic-class care and treatments in a setting local to our patient population," he says. "We have every tool we need to treat the most complex cases and know that future evolution will only expand that array of equipment. Even cancer patients far from our hospital will benefit, as Elekta takes much of the experience gained at Kettering and applies it to assist other departments to deliver the same type of care."

Building on its experience in treatment planning, Kettering has become a MOSAIQ Oncology Information System beta site and a Monaco treatment planning system alpha site, both of which allow direct communication between Elekta product management and Kettering's radiation oncology staff.

"This collaboration allows both parties to push forward together," Einstein adds, "With Elekta receiving immediate feedback on any issues, while Kettering receives the latest software and has an impact on desired future developments."

In addition, many of Kettering's radiation oncologists and staff members give presentations at a variety of national meetings.

"We attempt to not only showcase the Elekta hardware and software, but also assist our peers at the same time," he says. "Together we show that any center with the desire to provide high quality treatment can enter into a partnership with Elekta and have the tools to do it."

Kettering's association with Elekta includes its acquisition of linear accelerators it acquired nearly 20 years ago, and — over the years — Elekta treatment planning systems, oncology information systems and brachytherapy systems. Kettering also currently operates Elekta's Leksell Gamma Knife Perfexion radiosurgery system and Elekta Synergy radiotherapy system. In 2013, the center became the first U.S. hospital to install and begin using Elekta's state-of-the-art Versa HD radiation therapy system.

For more information: www.elekta.com

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init